Marginal effects of regional intra-arterial chemotherapy as an alternative treatment option in advanced pancreatic carcinoma

Langenbeck's Archives of Surgery

Volumn 389, Issue 1, 2004, Pages 32-39

  Meyer, Frank ^a   Grote, Reinhard ^a   Lippert, Hans ^a   Ridwelski, Karsten ^b  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b Dept of Gen and Abdominal Surgery   (Germany)

Author keywords

Intra arterial drug application; Locoregional chemotherapy; Pancreatic carcinoma

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL; FOLIC ACID ANTAGONIST; GEMCITABINE; HAEMATOFOLIN; MITOXANTRONE; ONCOHEXAL; STARCH MICROSPHERE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTERY CATHETER; ARTERY EMBOLISM; ARTERY THROMBOSIS; ARTICLE; BLOOD TOXICITY; BOLUS INJECTION; BONE MARROW DEPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CELIAC ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG INFUSION; DRUG RESPONSE; FEMALE; FEMORAL ARTERY; FEVER; HEMATOMA; HUMAN; INFECTION; LEUKOCYTE COUNT; LEUKOPENIA; MALE; MONOTHERAPY; NAUSEA; PANCREAS CARCINOMA; PRIORITY JOURNAL; SIDE EFFECT; STOMATITIS; SURVIVAL TIME; SYSTEMIC DISEASE; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MICROSPHERES; MIDDLE AGED; MITOXANTRONE; PANCREATIC NEOPLASMS; REMISSION INDUCTION; STARCH; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 1042288462     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-003-0431-1     Document Type: Article

References (33)

1. Matthias M, Wolff H (1987) Problems of antineoplastic chemotherapy of pancreatic cancer. Zentralbl Chir 112:1322-1336
2. Collins JM (1984) Pharmacologic rationale for regional drug delivery. J Clin Oncol 2:498-504
3. Schalhom A, Kuhl M (1995) Pharmacology of regional chemotherapy of colorectal liver metastases. Zentralbl Chir 120:764-768
4. Meta-Analysis Group (1996) Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88:252-258
5. Aigner KR, Santinami M (1994) Regional therapy for pelvic, rectal and urologic tumors: has it any role? Reg Cancer Treat 1:1
6. Aigner KR, Thiem N (1994) Regional chemotherapy for recurrent breast cancer-the effect of different techniques of drug administration on tumour response. Reg Cancer Treat 7:127-131
7. Itin AB (1972) Regional intra-arterial chemotherapy of cancer of the pancreas. Khirurgiia (Mosk) 148:22-25
8. Aigner KR, Müller H, Bassermann R (1990) Intra-arterial chemotherapy with MMC, CDDP and 5-FU for nonresectable pancreatic cancer-a phase II study. Reg Cancer Treat 3:1-6
9. Gansauge F, Link KH, Rilinger N, Kunz R, Beger HG (1995) Regional chemotherapy in advanced pancreatic carcinoma. Med Klin 90:501-505
10. Link KH, Formentini A, Gansauge F, Papachristov E, Beger HG (1997) Regional celiac artery infusion as adjuvant treatment after pancreatic cancer resection. Digestion 58:529-532
11. Link KH, Gansauge F, Pillasch J, Rilinger N, Buchler M, Beger HG (1994) Regional treatment of advanced nonresectable and of resected pancreatic cancer via celiac axis infusion. Dig Surg 11:414-419
12. Aigner KR, Gailhofer S, Kopp S (1998) Regional versus systemic chemotherapy for advanced pancreatic cancer: a randomized study. Hepatogastroenterology 45:1125-1129
13. Storniolo AM, Enas NH, Brown CA, Voi M, Rothenberg ML, Schilsky R (1999) An investigational new drug treatment program for patients with gemcitabine: results for over 3,000 patients with pancreatic carcinoma. Cancer 85:1261-1268
14. Schalhom A, Kuhl M (1992) Clinical pharmacokinetics of fluorouracil and folinic acid. Semin Oncol 19:82-92
15. Zeller WJ, Zur Hausen H (1995) Onkologie: Grundlagen-Diagnostik-Therapie-Entwicklungen. ecomed.-Losebl. 13[IV-3], 1-4. ecomed.- Losebl.-Ausg. NE, Landsberg/Lech (magazine article)
16. Gutman M, Abu-Abid S, Sorkine P, Inbar M, Lev D, Chen Z, Oron D, Chaitchik S, Klausner JM (1996) Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancer. Cancer 78:1125-1130
17. Shibuya K, Nagata Y, ltoh T, Okajima K, Murata R, Takagi T, Hiraoka M (1999) Transcatheter arterial infusion therapy in the treatment of advanced pancreatic cancer: a feasibility study. Cardiovasc Intervent Radiol 22:196-200
18. Grosso M, Zanon C, Zanon E, Corsico M, Gazzera C, Mancini A, Fava C (1997) The percutaneous placement of intra-arterial catheters with "reservoirs" for subcutaneous infusion. The technic and preliminary results. Radiol Med (Torino) 94:226-232
19. Tominaga M, Ku Y, Iwasaki T, Suzuki Y, Kuroda Y, Saitoh Y (1997) Pharmacological evaluation of portal venous isolation and charcoal haemoperfusion for high-dose intra-arterial chemotherapy of the pancreas. Br J Surg 84:1072-1076
20. Homma H, Doi T, Mezawa S (2000) A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization. Cancer 89:303-313
21. Muchmore JH, Carter RD, Preslan JE, George WJ (1996) Regional chemotherapy with hemofiltration: a rationale for a different treatment approach to advanced pancreatic cancer. Hepatogastroenterology 43:346-355
22. Muchmore JH, Preslan JE, George WJ (1996) Regional chemotherapy for inoperable pancreatic carcinoma. Cancer 78:664-673
23. Cantore M, Pederzoli P, Cornalba G, Fiorentini G, Guadagni S, Miserocchi L, Frassoldati A, Ceravolo C, Smerieri F, Muchmore JH (2000) Intra-arterial chemotherapy for unresectable pancreatic cancer. Ann Oncol 11:569-573
24. Ohigashi H, Ishikawa O, Imaoka S, Sasaki Y, Kabuto T, Kameyama M, Furukawa H, Hiratuka M, Nakamori S, Nakano H, Yasuda T, Iwanaga T (1996) A new method of intra-arterial regional chemotherapy with more selective drug delivery for locally advanced pancreatic cancer. Hepatogastroenterology 43:338-345
25. Hafstrom L, Ihse I, Jonsson PE, Lunderquist A, Stridbeck H (1980) Intraarterial 5-FU infusion with or without oral testolactone treatment in irresectable pancreatic cancer. Acta Chir Scand 146:445-448
26. Maurer CA, Borner MM, Lauffer J, Friess H, Z'graggen K, Triller J, Buchler MW (1998) Celiac axis infusion chemotherapy in advanced nonresectable pancreatic cancer. Int J Pancreatol 23:181-186
27. Theodors A, Bukowski RM, Hewlett JS, Livingston RB, Weick JK (1982) Intermittent regional infusion of chemotherapy for pancreatic adenocarcinoma. Phase I and II pilot study. Am J Clin Oncol 5:555-558
28. Adjei AA, Erlichman C (1999) A phase I trial of MTA and gemcitabine in patients with locally advanced or metastatic cancer. Semin Oncol 26:94-98
29. van Groeningen CJ (1999) Intravenous and intra-arterial chemotherapeutic possibilities in biliopancreatic cancer. Ann Oncol 10 [Suppl 4]:305-307
30. Lorenz M, Heinrich S, Staib-Sebler E, Kohne CH, Wils J, Nordlinger B, Encke A (2000) Regional chemotherapy in the treatment of advanced pancreatic cancer-is it relevant? Eur J Cancer 36:957-965
31. Stephens FO (1995) Induction (neoadjuvant) chemotherapy: systemic and arterial delivery techniques and their clinical applications. Aust N Z J Surg 65:699-707
32. Klapdor R, Seutter E, Lang-Polckow EM, Reichle H, Hinrichs A (1999) Locoregional/systemic chemotherapy of locally advanced/metastasized pancreatic cancer with a combination of mitomycin-C and gemcitabine and simultaneous follow-up by imaging methods and tumor markers. Anticancer Res 19:2459-2469
33. Müller H (1997) Angio-genesis-inhibition and intra-arterial chemotherapy-a new modality treatment for advanced metastatic pancreatic carcinoma. Eur J Cancer 33 [Suppl 8]:215-215